Concourse Financial Group Securities, Inc. Processa Pharmaceuticals, Inc. Transaction History

Concourse Financial Group Securities, Inc.

  • $1.64 Billion
  • Q3 2024

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 07, 2024
BUY
$0.18 - $0.84 $0 - $0
0 New
0 $0
Q3 2023

Oct 30, 2023
BUY
$0.24 - $0.53 $0 - $0
0 New
0 $0
Q3 2023

Oct 25, 2023
BUY
$0.24 - $0.53 $0 - $0
0 New
0 $0
Q2 2023

Aug 10, 2023
BUY
$0.44 - $0.73 $0 - $0
0 New
0 $0
Q1 2023

May 15, 2023
BUY
$0.41 - $1.3 $0 - $0
0 New
0 $0
Q4 2022

Jan 30, 2023
BUY
$1.1 - $50.0 $0 - $0
0 New
0 $0
Q3 2022

Nov 15, 2022
BUY
$2.0 - $46.8 $0 - $0
0 New
0 $0
Q2 2022

Aug 09, 2022
BUY
$1.68 - $3.55 $0 - $0
0 New
0 $0
Q1 2022

May 09, 2022
BUY
$3.01 - $5.21 $0 - $0
0 New
0 $0
Q4 2021

Feb 07, 2022
BUY
$4.03 - $8.42 $0 - $0
0 New
0 $0
Q3 2021

Nov 09, 2021
BUY
$5.28 - $8.61 $0 - $0
0 New
0 $0
Q2 2021

Aug 13, 2021
BUY
$6.15 - $10.95 $0 - $0
0 New
0 $0
Q1 2021

May 13, 2021
BUY
$5.96 - $13.15 $0 - $0
0 New
0 $0
Q4 2020

Feb 02, 2021
BUY
$3.95 - $8.48 $0 - $0
0 New
0 $0

About Processa Pharmaceuticals, Inc.

PCSA Quotes by TradingView
  • Ticker PCSA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 15,856,200
  • Market Cap $14.4M
  • Description
  • Processa Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development of drug products for the treatment of patients with unmet medical needs in the United States. Its lead product candidate is PCS499, an oral tablet that is in Phase 2B clinical trials for the treatment of ulcerative and non-ulcerative necrobiosi...
More about PCSA
Track This Portfolio

Track Concourse Financial Group Securities, Inc. Portfolio

Follow Concourse Financial Group Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email